Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol FBRX
- Company Forte Biosciences, Inc.
- Price $13.55
- Changes Percentage 143.71
- Change 7.99
- Day Low $8.79
- Day High $18.81
- Year High $21.25
- Year Low $4.11
- Market Cap $19,809,152
- Price Avg 50 EMA (D) $5.47
- Price Avg 200 EMA (D) $12.46
- Exchange NASDAQ
- Volume 29,415,905
- Average Volume 12,141
- Open $10.46
- Previous Close $5.56
- EPS -16.38
- PE -0.83
- Earnings Announcement 2025-03-17 04:00:00
- Shares Outstanding $1,461,930
Company brief: FORTE BIOSCIENCES, INC. (FBRX )
- Healthcare
- Biotechnology
- Dr. Paul A. Wagner Ph.D.
- https://www.fortebiorx.com
- US
- N/A
- 04-13-2017
- US34962G1094
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
FBRX Corporation News
Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?
zacks.com -- Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....